Format

Send to

Choose Destination
Int J Cancer. 1990 Sep 15;46(3):388-90.

Serum hyaluronan (hyaluronic acid) in breast cancer patients.

Author information

1
Centre RĂ©gional de Lutte Contre le Cancer Henri-Becquerel, Rouen, Paris, France.

Abstract

Eighty-three women with breast cancer (57 with systemic metastasis, 26 without) were investigated for serum hyaluronan (HA) and compared to 50 patients with benign diseases of the breast. Hyaluronan was significantly increased in sera of metastatic patients compared to sera of non-metastatic patients (p less than 0.0001) and also in sera of non-metastatic patients when compared to control sera (p less than 0.01). The difference was not related to the number of metastatic sites involved. Three months after starting cytotoxic chemotherapy in metastatic patients, lower HA concentrations were observed in patients responding to chemotherapy. The initial level of serum HA had no predictive value concerning response to chemotherapy.

PMID:
2394505
DOI:
10.1002/ijc.2910460309
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center